Reference attached quote; niehs / jothi; gemini bioproducts:1110293; pots [17-013138]
Ended Awarded Last action
- Contract number
- HHSN27300003
- Awardee
-
Gemini Bioproducts LLC UEI TPLGWKT6AM88
- Awarding agency
-
National Institute of Environmental Health Sciences
National Institutes of Health, Department of Health and Human Services
- Obligated
- $7,980
Award facts
- Contract value 100% obligated
- $7,980.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- PSC
- 6640 Laboratory Equipment And Supplies
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 3 offers Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Broderick, CA 95605, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$170 | |
| Original award | $8,150 |
About this award
This contract modification represents a deobligation of unused funds under a Blanket Purchase Agreement (BPA) call issued by the National Institute of Environmental Health Sciences (NIEHS), a component of the National Institutes of Health. The award to Gemini Bioproducts LLC, based in West Sacramento, California, carried a ceiling value of $7,980.00 under firm fixed-price terms. The original award date was September 25, 2017, with an ultimate completion date of May 17, 2022. No small business set-aside designation was applied to this procurement. Gemini Bioproducts, a established supplier of cell culture products, media, sera, and scientific reagents to federal research institutions, fulfilled the requirements under this vehicle with no applicable set-aside designation.
This modification relates to the $100 million single-award Blanket Purchase Agreement held by Gemini Bioproducts with the Office of Logistics and Acquisition Operations, which provides an ongoing supply mechanism for cell culture products, sera, antibiotics, media, reagents, and blood-related products to support the federal biomedical research ecosystem. The deobligation action reflects standard contract administration practices to return uncommitted funds to the government, ensuring efficient stewardship of appropriated resources while maintaining the company's capability to respond to future research needs across NIH-supported programs and initiatives.
Quick answers
Who was awarded contract HHSN27300003?
HHSN27300003 was awarded to Gemini Bioproducts LLC by National Institute of Environmental Health Sciences (National Institutes of Health) on September 25, 2017.
How much is contract HHSN27300003 worth?
The government has obligated $7,980 on HHSN27300003.
Is contract HHSN27300003 an order under another contract?
Yes. HHSN27300003 is a BPA call under HHSN263201500189B, a blanket purchase agreement.
Was contract HHSN27300003 competed?
The extent of competition for HHSN27300003 was competed under sap. The government received 3 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award